WHF IASC Roadmap on Chagas Disease

Autores
Echeverría, Luis Eduardo; Marcus, Rachel; Novick, Gabriel; Sosa-Estani, Sergio Alejandro; Ralston, Kate; Zaidel, Ezequiel Jose; Forsyth, Colin; RIbeiro, Antonio Luiz P.; Mendoza, Iván; Falconi, Mariano Luis; Mitelman, Jorge Eduardo; Morillo, Carlos A.; Pereiro, Ana Cristina; Pinazo, María Jesús; Salvatella, Roberto; Martinez, Felipe; Perel, Pablo; Sosa Liprandi, Álvaro; Piñeiro, Daniel José; Restrepo Molina, Gustavo
Año de publicación
2020
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Background: Chagas Disease is a neglected tropical disease caused by the protozoan Trypanosoma cruzi, with some of the most serious manifestations affecting the cardiovascular system. It is a chronic, stigmatizing condition, closely associated with poverty and affecting close to 6 million people globally. Although historically the disease was limited to endemic areas of Latin America recent years have seen an increasing global spread. In addition to the morbidity and mortality associated with the disease, the social and economic burdens on individuals and society are substantial. Often called the 'silent killer', Chagas disease is characterized by a long, asymptomatic phase in affected individuals. Approximately 30% then go on develop chronic Chagas cardiomyopathy and other serious cardiac complications such as stroke, rhythm disturbances and severe heart failure. Methods: In a collaboration of the World Hearth Federation (WHF) and the Inter-American Society of Cardiology (IASC) a writing group consisting of 20 diverse experts on Chagas disease (CD) was convened. The group provided up to date expert knowledge based on their area of expertise. An extensive review of the literature describing obstacles to diagnosis and treatment of CD along with proposed solutions was conducted. A survey was sent to all WHF Members and, using snowball sampling to widen the consultation, to a variety of health care professionals working in the CD global health community. The results were analyzed, open comments were reviewed and consolidated, and the findings were incorporated into this document, thus ensuring a consensus representation. Results: The WHF IASC Roadmap on Chagas Disease offers a comprehensive summary of current knowledge on prevention, diagnosis and management of the disease. In providing an analysis of 'roadblocks' in access to comprehensive care for Chagas disease patients, the document serves as a framework from which strategies for implementation such as national plans can be formulated. Several dimensions are considered in the analysis: healthcare system capabilities, governance, financing, community awareness and advocacy. Conclusion: The WHF IASC Roadmap proposes strategies and evidence-based solutions for healthcare professionals, health authorities and governments to help overcome the barriers to comprehensive care for Chagas disease patients. This roadmap describes an ideal patient care pathway, and explores the roadblocks along the way, offering potential solutions based on available research and examples in practice. It represents a call to action to decision-makers and health care professionals to step up efforts to eradicate Chagas disease.
Fil: Echeverría, Luis Eduardo. Cardiovascular Foundation Of Colombia; Colombia
Fil: Marcus, Rachel. Union Memorial Hospital; Estados Unidos
Fil: Novick, Gabriel. Tufts University; Estados Unidos
Fil: Sosa-Estani, Sergio Alejandro. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones en Epidemiología y Salud Pública. Instituto de Efectividad Clínica y Sanitaria. Centro de Investigaciones en Epidemiología y Salud Pública; Argentina
Fil: Ralston, Kate. World Heart Federation; Suiza
Fil: Zaidel, Ezequiel Jose. Universidad de Buenos Aires; Argentina
Fil: Forsyth, Colin. Drugs For Neglected Diseases Initiative; Estados Unidos
Fil: RIbeiro, Antonio Luiz P.. Universidade Federal de Minas Gerais; Brasil
Fil: Mendoza, Iván. Universidad Central de Venezuela; Venezuela
Fil: Falconi, Mariano Luis. Hospital Italiano; Argentina
Fil: Mitelman, Jorge Eduardo. Universidad de Buenos Aires; Argentina
Fil: Morillo, Carlos A.. University of Calgary; Canadá
Fil: Pereiro, Ana Cristina. Fundación Mundo Sano; Argentina
Fil: Pinazo, María Jesús. Universidad de Barcelona; España
Fil: Salvatella, Roberto. No especifíca;
Fil: Martinez, Felipe. Universidad Nacional de Córdoba; Argentina
Fil: Perel, Pablo. No especifíca;
Fil: Sosa Liprandi, Álvaro. Universidad de Buenos Aires; Argentina
Fil: Piñeiro, Daniel José. Universidad de Buenos Aires; Argentina
Fil: Restrepo Molina, Gustavo. Universidad Ces; Colombia
Materia
CARDIOMYOPATHY
CHAGAS DISEASE
HEART FAILURE
NEGLECTED TROPICAL DISEASE
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/142697

id CONICETDig_d01b827e79189cee432d4225270ddab7
oai_identifier_str oai:ri.conicet.gov.ar:11336/142697
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling WHF IASC Roadmap on Chagas DiseaseEcheverría, Luis EduardoMarcus, RachelNovick, GabrielSosa-Estani, Sergio AlejandroRalston, KateZaidel, Ezequiel JoseForsyth, ColinRIbeiro, Antonio Luiz P.Mendoza, IvánFalconi, Mariano LuisMitelman, Jorge EduardoMorillo, Carlos A.Pereiro, Ana CristinaPinazo, María JesúsSalvatella, RobertoMartinez, FelipePerel, PabloSosa Liprandi, ÁlvaroPiñeiro, Daniel JoséRestrepo Molina, GustavoCARDIOMYOPATHYCHAGAS DISEASEHEART FAILURENEGLECTED TROPICAL DISEASEhttps://purl.org/becyt/ford/3.3https://purl.org/becyt/ford/3Background: Chagas Disease is a neglected tropical disease caused by the protozoan Trypanosoma cruzi, with some of the most serious manifestations affecting the cardiovascular system. It is a chronic, stigmatizing condition, closely associated with poverty and affecting close to 6 million people globally. Although historically the disease was limited to endemic areas of Latin America recent years have seen an increasing global spread. In addition to the morbidity and mortality associated with the disease, the social and economic burdens on individuals and society are substantial. Often called the 'silent killer', Chagas disease is characterized by a long, asymptomatic phase in affected individuals. Approximately 30% then go on develop chronic Chagas cardiomyopathy and other serious cardiac complications such as stroke, rhythm disturbances and severe heart failure. Methods: In a collaboration of the World Hearth Federation (WHF) and the Inter-American Society of Cardiology (IASC) a writing group consisting of 20 diverse experts on Chagas disease (CD) was convened. The group provided up to date expert knowledge based on their area of expertise. An extensive review of the literature describing obstacles to diagnosis and treatment of CD along with proposed solutions was conducted. A survey was sent to all WHF Members and, using snowball sampling to widen the consultation, to a variety of health care professionals working in the CD global health community. The results were analyzed, open comments were reviewed and consolidated, and the findings were incorporated into this document, thus ensuring a consensus representation. Results: The WHF IASC Roadmap on Chagas Disease offers a comprehensive summary of current knowledge on prevention, diagnosis and management of the disease. In providing an analysis of 'roadblocks' in access to comprehensive care for Chagas disease patients, the document serves as a framework from which strategies for implementation such as national plans can be formulated. Several dimensions are considered in the analysis: healthcare system capabilities, governance, financing, community awareness and advocacy. Conclusion: The WHF IASC Roadmap proposes strategies and evidence-based solutions for healthcare professionals, health authorities and governments to help overcome the barriers to comprehensive care for Chagas disease patients. This roadmap describes an ideal patient care pathway, and explores the roadblocks along the way, offering potential solutions based on available research and examples in practice. It represents a call to action to decision-makers and health care professionals to step up efforts to eradicate Chagas disease.Fil: Echeverría, Luis Eduardo. Cardiovascular Foundation Of Colombia; ColombiaFil: Marcus, Rachel. Union Memorial Hospital; Estados UnidosFil: Novick, Gabriel. Tufts University; Estados UnidosFil: Sosa-Estani, Sergio Alejandro. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones en Epidemiología y Salud Pública. Instituto de Efectividad Clínica y Sanitaria. Centro de Investigaciones en Epidemiología y Salud Pública; ArgentinaFil: Ralston, Kate. World Heart Federation; SuizaFil: Zaidel, Ezequiel Jose. Universidad de Buenos Aires; ArgentinaFil: Forsyth, Colin. Drugs For Neglected Diseases Initiative; Estados UnidosFil: RIbeiro, Antonio Luiz P.. Universidade Federal de Minas Gerais; BrasilFil: Mendoza, Iván. Universidad Central de Venezuela; VenezuelaFil: Falconi, Mariano Luis. Hospital Italiano; ArgentinaFil: Mitelman, Jorge Eduardo. Universidad de Buenos Aires; ArgentinaFil: Morillo, Carlos A.. University of Calgary; CanadáFil: Pereiro, Ana Cristina. Fundación Mundo Sano; ArgentinaFil: Pinazo, María Jesús. Universidad de Barcelona; EspañaFil: Salvatella, Roberto. No especifíca;Fil: Martinez, Felipe. Universidad Nacional de Córdoba; ArgentinaFil: Perel, Pablo. No especifíca;Fil: Sosa Liprandi, Álvaro. Universidad de Buenos Aires; ArgentinaFil: Piñeiro, Daniel José. Universidad de Buenos Aires; ArgentinaFil: Restrepo Molina, Gustavo. Universidad Ces; ColombiaWorld Heart Federation2020-03info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/142697Echeverría, Luis Eduardo; Marcus, Rachel; Novick, Gabriel; Sosa-Estani, Sergio Alejandro; Ralston, Kate; et al.; WHF IASC Roadmap on Chagas Disease; World Heart Federation; Global Heart; 15; 1; 3-2020; 1-312211-8179CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.5334/gh.484info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T10:27:51Zoai:ri.conicet.gov.ar:11336/142697instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 10:27:52.18CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv WHF IASC Roadmap on Chagas Disease
title WHF IASC Roadmap on Chagas Disease
spellingShingle WHF IASC Roadmap on Chagas Disease
Echeverría, Luis Eduardo
CARDIOMYOPATHY
CHAGAS DISEASE
HEART FAILURE
NEGLECTED TROPICAL DISEASE
title_short WHF IASC Roadmap on Chagas Disease
title_full WHF IASC Roadmap on Chagas Disease
title_fullStr WHF IASC Roadmap on Chagas Disease
title_full_unstemmed WHF IASC Roadmap on Chagas Disease
title_sort WHF IASC Roadmap on Chagas Disease
dc.creator.none.fl_str_mv Echeverría, Luis Eduardo
Marcus, Rachel
Novick, Gabriel
Sosa-Estani, Sergio Alejandro
Ralston, Kate
Zaidel, Ezequiel Jose
Forsyth, Colin
RIbeiro, Antonio Luiz P.
Mendoza, Iván
Falconi, Mariano Luis
Mitelman, Jorge Eduardo
Morillo, Carlos A.
Pereiro, Ana Cristina
Pinazo, María Jesús
Salvatella, Roberto
Martinez, Felipe
Perel, Pablo
Sosa Liprandi, Álvaro
Piñeiro, Daniel José
Restrepo Molina, Gustavo
author Echeverría, Luis Eduardo
author_facet Echeverría, Luis Eduardo
Marcus, Rachel
Novick, Gabriel
Sosa-Estani, Sergio Alejandro
Ralston, Kate
Zaidel, Ezequiel Jose
Forsyth, Colin
RIbeiro, Antonio Luiz P.
Mendoza, Iván
Falconi, Mariano Luis
Mitelman, Jorge Eduardo
Morillo, Carlos A.
Pereiro, Ana Cristina
Pinazo, María Jesús
Salvatella, Roberto
Martinez, Felipe
Perel, Pablo
Sosa Liprandi, Álvaro
Piñeiro, Daniel José
Restrepo Molina, Gustavo
author_role author
author2 Marcus, Rachel
Novick, Gabriel
Sosa-Estani, Sergio Alejandro
Ralston, Kate
Zaidel, Ezequiel Jose
Forsyth, Colin
RIbeiro, Antonio Luiz P.
Mendoza, Iván
Falconi, Mariano Luis
Mitelman, Jorge Eduardo
Morillo, Carlos A.
Pereiro, Ana Cristina
Pinazo, María Jesús
Salvatella, Roberto
Martinez, Felipe
Perel, Pablo
Sosa Liprandi, Álvaro
Piñeiro, Daniel José
Restrepo Molina, Gustavo
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv CARDIOMYOPATHY
CHAGAS DISEASE
HEART FAILURE
NEGLECTED TROPICAL DISEASE
topic CARDIOMYOPATHY
CHAGAS DISEASE
HEART FAILURE
NEGLECTED TROPICAL DISEASE
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.3
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv Background: Chagas Disease is a neglected tropical disease caused by the protozoan Trypanosoma cruzi, with some of the most serious manifestations affecting the cardiovascular system. It is a chronic, stigmatizing condition, closely associated with poverty and affecting close to 6 million people globally. Although historically the disease was limited to endemic areas of Latin America recent years have seen an increasing global spread. In addition to the morbidity and mortality associated with the disease, the social and economic burdens on individuals and society are substantial. Often called the 'silent killer', Chagas disease is characterized by a long, asymptomatic phase in affected individuals. Approximately 30% then go on develop chronic Chagas cardiomyopathy and other serious cardiac complications such as stroke, rhythm disturbances and severe heart failure. Methods: In a collaboration of the World Hearth Federation (WHF) and the Inter-American Society of Cardiology (IASC) a writing group consisting of 20 diverse experts on Chagas disease (CD) was convened. The group provided up to date expert knowledge based on their area of expertise. An extensive review of the literature describing obstacles to diagnosis and treatment of CD along with proposed solutions was conducted. A survey was sent to all WHF Members and, using snowball sampling to widen the consultation, to a variety of health care professionals working in the CD global health community. The results were analyzed, open comments were reviewed and consolidated, and the findings were incorporated into this document, thus ensuring a consensus representation. Results: The WHF IASC Roadmap on Chagas Disease offers a comprehensive summary of current knowledge on prevention, diagnosis and management of the disease. In providing an analysis of 'roadblocks' in access to comprehensive care for Chagas disease patients, the document serves as a framework from which strategies for implementation such as national plans can be formulated. Several dimensions are considered in the analysis: healthcare system capabilities, governance, financing, community awareness and advocacy. Conclusion: The WHF IASC Roadmap proposes strategies and evidence-based solutions for healthcare professionals, health authorities and governments to help overcome the barriers to comprehensive care for Chagas disease patients. This roadmap describes an ideal patient care pathway, and explores the roadblocks along the way, offering potential solutions based on available research and examples in practice. It represents a call to action to decision-makers and health care professionals to step up efforts to eradicate Chagas disease.
Fil: Echeverría, Luis Eduardo. Cardiovascular Foundation Of Colombia; Colombia
Fil: Marcus, Rachel. Union Memorial Hospital; Estados Unidos
Fil: Novick, Gabriel. Tufts University; Estados Unidos
Fil: Sosa-Estani, Sergio Alejandro. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones en Epidemiología y Salud Pública. Instituto de Efectividad Clínica y Sanitaria. Centro de Investigaciones en Epidemiología y Salud Pública; Argentina
Fil: Ralston, Kate. World Heart Federation; Suiza
Fil: Zaidel, Ezequiel Jose. Universidad de Buenos Aires; Argentina
Fil: Forsyth, Colin. Drugs For Neglected Diseases Initiative; Estados Unidos
Fil: RIbeiro, Antonio Luiz P.. Universidade Federal de Minas Gerais; Brasil
Fil: Mendoza, Iván. Universidad Central de Venezuela; Venezuela
Fil: Falconi, Mariano Luis. Hospital Italiano; Argentina
Fil: Mitelman, Jorge Eduardo. Universidad de Buenos Aires; Argentina
Fil: Morillo, Carlos A.. University of Calgary; Canadá
Fil: Pereiro, Ana Cristina. Fundación Mundo Sano; Argentina
Fil: Pinazo, María Jesús. Universidad de Barcelona; España
Fil: Salvatella, Roberto. No especifíca;
Fil: Martinez, Felipe. Universidad Nacional de Córdoba; Argentina
Fil: Perel, Pablo. No especifíca;
Fil: Sosa Liprandi, Álvaro. Universidad de Buenos Aires; Argentina
Fil: Piñeiro, Daniel José. Universidad de Buenos Aires; Argentina
Fil: Restrepo Molina, Gustavo. Universidad Ces; Colombia
description Background: Chagas Disease is a neglected tropical disease caused by the protozoan Trypanosoma cruzi, with some of the most serious manifestations affecting the cardiovascular system. It is a chronic, stigmatizing condition, closely associated with poverty and affecting close to 6 million people globally. Although historically the disease was limited to endemic areas of Latin America recent years have seen an increasing global spread. In addition to the morbidity and mortality associated with the disease, the social and economic burdens on individuals and society are substantial. Often called the 'silent killer', Chagas disease is characterized by a long, asymptomatic phase in affected individuals. Approximately 30% then go on develop chronic Chagas cardiomyopathy and other serious cardiac complications such as stroke, rhythm disturbances and severe heart failure. Methods: In a collaboration of the World Hearth Federation (WHF) and the Inter-American Society of Cardiology (IASC) a writing group consisting of 20 diverse experts on Chagas disease (CD) was convened. The group provided up to date expert knowledge based on their area of expertise. An extensive review of the literature describing obstacles to diagnosis and treatment of CD along with proposed solutions was conducted. A survey was sent to all WHF Members and, using snowball sampling to widen the consultation, to a variety of health care professionals working in the CD global health community. The results were analyzed, open comments were reviewed and consolidated, and the findings were incorporated into this document, thus ensuring a consensus representation. Results: The WHF IASC Roadmap on Chagas Disease offers a comprehensive summary of current knowledge on prevention, diagnosis and management of the disease. In providing an analysis of 'roadblocks' in access to comprehensive care for Chagas disease patients, the document serves as a framework from which strategies for implementation such as national plans can be formulated. Several dimensions are considered in the analysis: healthcare system capabilities, governance, financing, community awareness and advocacy. Conclusion: The WHF IASC Roadmap proposes strategies and evidence-based solutions for healthcare professionals, health authorities and governments to help overcome the barriers to comprehensive care for Chagas disease patients. This roadmap describes an ideal patient care pathway, and explores the roadblocks along the way, offering potential solutions based on available research and examples in practice. It represents a call to action to decision-makers and health care professionals to step up efforts to eradicate Chagas disease.
publishDate 2020
dc.date.none.fl_str_mv 2020-03
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/142697
Echeverría, Luis Eduardo; Marcus, Rachel; Novick, Gabriel; Sosa-Estani, Sergio Alejandro; Ralston, Kate; et al.; WHF IASC Roadmap on Chagas Disease; World Heart Federation; Global Heart; 15; 1; 3-2020; 1-31
2211-8179
CONICET Digital
CONICET
url http://hdl.handle.net/11336/142697
identifier_str_mv Echeverría, Luis Eduardo; Marcus, Rachel; Novick, Gabriel; Sosa-Estani, Sergio Alejandro; Ralston, Kate; et al.; WHF IASC Roadmap on Chagas Disease; World Heart Federation; Global Heart; 15; 1; 3-2020; 1-31
2211-8179
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/doi/10.5334/gh.484
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv World Heart Federation
publisher.none.fl_str_mv World Heart Federation
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1844614281438429184
score 13.070432